U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Pharmaceutical tablet composition

Patent 5601843 Issued on February 11, 1997. Estimated Expiration Date: Icon_subject July 18, 2014. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Patent References

Peptic ulcer treatment method
Patent #: 4707495
Issued on: 11/17/1987
Inventor: Rosenthale ,   et al.

Derivatives of 19,20-Bis-nor-prostanoic acid with antiulcer and anorectic activity, process for their preparation and pharmaceutical compositions thereof
Patent #: 4816472
Issued on: 03/28/1989
Inventor: Valcavi

Gastric mucosa protective agents
Patent #: 4865847
Issued on: 09/12/1989
Inventor: Gosswein

Anti-ulcer composition
Patent #: 4954512
Issued on: 09/04/1990
Inventor: Oguro, et al.

Stabilized enteric coated aspirin granules and process for preparation Patent #: 4975283
Issued on: 12/04/1990
Inventor: Patell

Inventors

Application

No. 276299 filed on 07/18/1994

US Classes:

424/475, Organic coatings424/464, Tablets, lozenges, or pills424/472, Layered unitary dosage forms424/474, Coated pills or tablets424/476, Containing waxes, higher fatty acids, higher fatty alcohols, or derivatives thereof (e.g., chocolate)514/573Cyclopentyl or cyclopentene (e.g., prostaglandins, etc.)

Examiners

Primary: Kishore, Gollamudi S.

Attorney, Agent or Firm

Foreign Patent References

  • 2135881 GB 09/13/1984

International Classes

A61K 009/30
A61K 009/28

Abstract

A pharmaceutical composition including a core of an NSAID selected from diclofenac and piroxicam which core is surrounded by a mantle coating of a prostaglandin, wherein an intermediate coating can be present between the NSAID core and prostaglandin mantle coating.

Other References

  • IMS Market letter May 1987 vol. 14
  • James et al. Arzneimittelforschung Hyperalgesia after treatment of mice with etc. 28 804-7 Jan. 1978
  • Mikami et al. J. Pharm. Pharmacol. The Potentiating effects of prostaglandins on etc. 31 856-7 Jan. 1979
  • Walter et al. Agents and Actions Effects of analgesics on bradykin-induced etc. 27 375-7 Jan. 1979
  • Taiwo et al. J. Neurosci. Prostaglandins Inhibit Endogenous Pain Control etc. 8 1346-9 Jan. 1988
  • Pateromichelakis et. Brain Research Prostaglandin E1-induced sensitization of Aa etc. 232 89-96 Jan. 1982
  • Sanyal et al. Clin. Exp. Pharmacol. Physiol. Prostaglandins: antinociceptive effect of etc. 4 247-55 Jan. 1977
  • Bhattacharya et al. Clin. Exp. Pharmacol. Physiol. Potentiation of antinociceptive action of etc. 2 353-357 Jan. 1975
  • Ferri et al. Psychopharmacologia Decreased antinociceptive effect of morphine etc. 39 231-5 Jan. 1974
  • Sanyal et al. Psychopharmacology The antinociceptive effect of etc. 60 159-63 Jan. 1979
  • G. D. Searle & Co. Physician's Desk Reference Cytotec (misoprostol) Drug Information 44 2056-7 Jan. 1990
  • IMS IMS Marketletter IMS Marketletter Apr. 198
PatentsPlus Images
Enhanced PDF formats
loading...
PatentsPlus: add to cart
PatentsPlus: add to cartSearch-enhanced full patent PDF image
$9.95more info
PatentsPlus: add to cart
PatentsPlus: add to cartIntelligent turbocharged patent PDFs with marked up images
$16.95more info
 
Sign InRegister
Username  
Password   
forgot password?